Sonapax 25mg 60 tablets — Made in Poland — Free Delivery

Mental and emotional disorders, accompanied by fear, anxiety, agitation. In psychiatric practice: acute and subacute schizophrenia, organic psychosis, psychomotor agitation, manic-depressive states, neurosis, alcohol withdrawal syndrome, mental behavioral disorders in children, agitation in elderly patients.

Hypersensitivity to phenothiazine derivatives or to any component of the preparation. Thioridazine is contraindicated in patients with the following conditions: clinically important cardiac disorders (heart failure, angina pectoris, cardiomyopathy or left ventricular dysfunction) - long QTc interval syndrome, family history of long QTc interval syndrome. Since thioridazine prolongs the QTc interval, it is also contraindicated in the competitive use of preparations that also can prolong the QTc interval. Ventricular arrhythmia, incl. a history of bradycardia, SA or II-III degree conduction block, uncorrected hypokalemia or hypomagnesemia. Cardiac arrhythmia in history, severe arterial hypotension, pheochromocytoma, porphyria, blood diseases (hypo- and aplastic processes), simultaneous use with fluoxetine, paroxetine, propranolol, Pindolol, fluvoxamine, genetic disorders leading to a decrease in the activity level of 450 2D6. Severe photosensitivity, severe depressive states, coma of any etiology, dementia, traumatic brain injury, progressive systemic diseases of the brain and spinal cord.

active ingredient: thioridazine hydrochloride 1 coated tablet contains thioridazine hydrochloride 10 mg or 25 mg excipients: coated tablets, 10 mg: corn starch, colloidal silicon dioxide, sucrose, lactose, gelatin, stearic acid, talc, gum arabic ( E 414), cochineal red A (E 124) coated tablets, 25 mg: potato starch, sucrose, gelatin, gum arabic (E 414), magnesium stearate, sucrose, talc, quinoline yellow (E 104).

Doses are set by the doctor individually, the lowest therapeutically effective dose is determined for each patient separately. Divide the daily dose into 2-4 doses. Adults and teenagers. Mental and emotional disorders such as schizophrenia, manic psychosis and similar conditions: 150-600 mg per day. The initial dose may be increased to 200 mg for patients with acute schizophrenia. The daily dose can be increased up to 800 mg in resistant patients under the supervision of a physician, but not more than within 4 weeks. Treatment of psychosis on an outpatient basis: a daily dose of ˗50-300 mg, in patients with depression and elderly patients - 25-200 mg, alcohol withdrawal syndrome - 100-200 mg, severe mental disorders of a non-psychotic nature ˗ 25-150 mg. As a sedative and tranquilizer, Sonapax ® is prescribed for adults at a daily dose of 10-75 mg. Usual doses for pediatric use. Children 5-12 years old: 0.25-3 mg per 1 kg of body weight per day in 2-4 doses. Severe violations: 25 mg 2-3 times a day. The maximum daily dose is 300 mg. At a dosage not a multiple of 25 mg, thioridazine should be used in appropriate dosage forms and dosages.